최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea, v.26 no.11, 2003년, pp.892 - 897
Liu, Wen-Sheng , Huang, Yuan , Zhang, Zhi-Rong
Anticancer drugs have serious side effects arising from their poor malignant cells selectivity. Since insulin receptors highly express on the cytomembrane of some kind of tumor cells, using insulin as the vector was expected to reduce serious side effects of the drugs. The objective of this study wa...
Clin. Pharmacokine. G. Ehninger 18 365 1990 10.2165/00003088-199018050-00003 Ehninger, G., Schuler, U., and Porksch, B., Pharmacokinetics and metabolism of Mitoxantrone.Clin. Pharmacokine., 18, 365-80 (1990).
Cancer Left. T. Hanafusa 176 149 2002 10.1016/S0304-3835(01)00736-4 Hanafusa, T., Yumoto, Y, and Nouso, K., Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma.Cancer Left., 176, 149-158 (2002).
Cell Growth Differ. H. Huynh 13 115 2002 Huynh, H., Chow, P. K., and Ooi, L. L., A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.Cell Growth Differ., 13, 115-122 (2002).
Anticancer Res. G. Koutions 22 815 2002 Koutions, G., Stathopoulos, G. P., and Dontas, I., The effect of Doxrubicine and its analogue mitoxantrone on cardiac muscle and on serum lipids: an experimental study.Anticancer Res., 22, 815-820 (2002).
J. Nucl. Med. A. Kurtaran 36 1875 1995 Kurtaran, A., Li, S. R., and Raderer, M., Technetium-99m-galactocyl-neoglycoalyco-albumin combined with iodine-123 Tyr(A14) insulin visualized human hepatocellular carcinomas.J. Nucl. Med., 36, 1875-1881 (1995).
Hepatology Y. Oka 35 1153 2002 10.1053/jhep.2002.32669 Oka, Y., Waterland, R. A., and Killian, J. K., M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan.Hepatology, 35, 1153-1163 (2002).
J. Biomedical Engineering X. H. Ou 17 87 2000 Ou, X. H. and Kuang, A. R., The use of insulin as carrier in targeted therapy.J. Biomedical Engineering, 17, 87-90 (2000).
Surgery S. Tanaka 131 142 2002 10.1067/msy.2002.119495 Tanaka, S., Sugimachi, K., and Maehara, S., Oncogenic signal transduction and therapeutic strategy for hepatocellular carcinoma.Surgery, 131, S142-147 (2002).
Nature M. A. Theresa 2 750 2002 Theresa, M. A., Ligand-targeted therapeutics in anticancer therapy.Nature, 2, 750-761 (2002).
Cancer Lett. H. Horn Von 162 253 2001 10.1016/S0304-3835(00)00668-6 Von Horn, H., Tally, M., and Hall, K., Expression levels of insulin-like growth factor binding proteins and insulin receptor isoforms in hepatoblastomas.Cancer Lett., 162, 253-260 (2001).
European J. Pharmaceutics Biopharmaceutics J. X. Wang 54 285 2002 10.1016/S0939-6411(02)00083-8 Wang, J. X., Sun, X., and Zhang, Z. R., Enhanced brain targeting by synthesis of 3,5-dioctanoyl-5-fluoro-2-deoxyuridine and incorporation into solid lipid nanoparticles.European J. Pharmaceutics Biopharmaceutics, 54, 285-290 (2002).
Chi. J. Hospital Pharmacy Z. R. Zhang 19 140 1999 Zhang, Z. R. and Zhang, Q. Z., Comparison of liver targeting effect of mitoxantrone-bovine serum albumin-microspheres with galactosyl-mitoxantrone-bovine serum albumin-microspheres.Chi. J. Hospital Pharmacy, 19, 140-141 (1999).
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Free Access. 출판사/학술단체 등이 허락한 무료 공개 사이트를 통해 자유로운 이용이 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.